Technical advances in NK cell-based cellular immunotherapy

Fang Fang, Wei Wang, Minhua Chen, et al.


Natural killer (NK) cells represent a promising future for tumor immunotherapy because of their unique biological functions andcharacteristics. This review focuses on technical advances in NK cell-based cellular immunotherapy and summarizes thedevelopments of recent years in cell sources, genetic modification, manufacturing systems, clinical programs, and outcomes.Future prospects and challenges in NK cell immunotherapy are also discussed, including off-the-shelf NK cell exploitation,automatic and closed manufacturing systems, cryopreservation, and therapies involving regulatory checkpoints.

Cite this article as: Fang F, Wang W, Chen M, Tian Z, Xiao W. Technicaladvances in NK cell-based cellular immunotherapy. Cancer Biol Med. 2019;16: 647-54. doi: 10.20892/j.issn.2095-3941.2019.0187


Natural killer cell; immunotherapy; adoptive cell transfer; genetic modification

Full Text: PDF HTML


  • There are currently no refbacks.